Plasminogen Activator Inhibitor-1 (PAI-1) Genotypi

The PAI-1 test measures the level of plasminogen activator inhibitor-1 in the blood. PAI-1 is a protein that regulates blood clot formation by inhibiting tissue plasminogen activator (tPA). Abnormal PAI-1 levels are associated with an increased risk of thrombosis and cardiovascular disease.

The test is recommended for individuals with a personal or family history of thrombosis, recurrent miscarriages, or unexplained cardiovascular events. It is also used to assess clotting disorders and monitor patients undergoing fibrinolytic therapy.

A blood sample is collected, and PAI-1 levels are measured using immunoassay techniques. The results help determine whether abnormal levels of PAI-1 are contributing to an increased risk of clot formation or impaired fibrinolysis.

Elevated PAI-1 levels indicate a higher risk of clot formation, potentially leading to thrombotic events such as deep vein thrombosis (DVT) and myocardial infarction. Low PAI-1 levels may increase the risk of excessive bleeding due to impaired clot formation.

Management strategies may include anticoagulant therapy, lifestyle modifications, and addressing underlying conditions that may contribute to abnormal PAI-1 levels. Regular monitoring is essential for individuals at high risk of thrombotic events.